Latest Advocacy Group Content

Clinical Trials Can Be Scary – But with Advice From Past Participants, They Don’t Have To Be

Real-World Patients May Have More Side Effects to Immunotherapy for Lung Cancer Compared With Clinical Trial Data

Blue Note Therapeutics Partners With Several Nonprofits, Advocacy Groups to Deliver Digital Cancer-Related Mental Health Care Amid COVID-19 Pandemic

Friday Frontline: An Oncologist Forgives $650,00 in Medical Debt From His Patients, ‘Saved By The Bell’ Star Dustin Diamond Diagnosed with Stage 4 Cancer, And More

View More

Latest Content

FDA Grants Priority Review for Opdivo for Several Gastrointestinal Cancers

January 20th 2021, 4:00pm

By Darlene Dobkowski, MA

Article

The priority review will focus on Opdivo with chemotherapy for the treatment several gastrointestinal cancers, which has recently become a rising area in novel treatment development.

Inlyta-Synthetic Hormone Combo Fails to Significantly Improve Survival Outcome in Pancreatic Neuroendocrine Tumors

January 20th 2021, 2:00pm

By Ryan McDonald

Article

The combination of Inlyta (axitinib) and the synthetic hormone octreotide acetate failed to significantly improve progression-free survival, compared to placebo with the synthetic hormone. However, the results indicated the Inlyta-based combination did improve disease response in patients versus the placebo-based combination.

Avastin-Lonsurf Combo Improves Survival in Patients with Metastatic Colorectal Cancer Ineligible for Standard Chemo

January 19th 2021, 10:00pm

By Ryan McDonald

Article

In the final analysis of the phase 2 TASCO1 trial, patients within the Lonsurf and Avastin arm reached a median overall survival of 22.31 months compared with 17.67 months in the Xeloda and Avastin arm.

Tecentriq-Avastin Combo Continues to Show Improved Survival Benefit in Patients with Advanced Liver Cancer

January 19th 2021, 7:00pm

By Ryan McDonald

Article

“This is the longest survival seen in a phase 3 study of advanced liver cancer,” lead study author Dr. Richard S. Finn, of the UCLA Jonsson Comprehensive Cancer Center, said in a virtual presentation of the data.

The Balancing Act of Being a Cancer Caregiver and Parent

January 19th 2021, 5:00pm

By Debbie Legault

Article

The balancing act of being a caregiver and parent simultaneously is one that requires acceptance and fierceness.

Advanced-Stage Rare Type of Gastrointestinal Cancer More Common in Men, Associated with ‘Excellent’ 5-Year Survival Rates

January 19th 2021, 4:00pm

By Ryan McDonald

Article

The data in the study presented at the ASCO Gastrointestinal Cancers Symposium demonstrated that while rare, stage 4 gastrointestinal stromal tumors often spread to the liver.

Learning the Basics of a Rare Disease: Cutaneous T-Cell Lymphoma

January 19th 2021, 2:00pm

By Kristie L. Kahl

Video

On behalf of the Cutaneous Lymphoma Foundation, CURE spoke with Drs. Steven M. Horwitz and Lauren Pinter-Brown about the basics of cutaneous T-cell lymphoma, as well as current treatment options and those being evaluated for the rare disease.

Novel Artificial Intelligence Tool May Help Patients with Cancer Find, Understand Clinical Trials

January 18th 2021, 10:00pm

By Ryan McDonald

Article

A group of patients with gastrointestinal cancers reported that a novel artificial intelligence-based search tool made it easier for them to find and understand cancer clinical trials. The tool, according to study authors, would not only help with trial accrual, but could also help improve trial diversity.

7 Recent Cancer Drug Approvals Patients May Have Missed

January 18th 2021, 7:00pm

By Ryan McDonald

Article

The Food and Drug Administration has had a busy winter so far, approving several new agents to treat a variety of cancers. Here are seven recent approvals that patients with cancer may have missed.

Living One Day Longer Than My Father

January 18th 2021, 5:00pm

By Khevin Barnes

Article

As a cancer survivor, I’ve found many reasons to celebrate. Here’s one more.

For Younger Patients, CAR T-Cell Therapy Could Play a Role in CLL Treatment

January 18th 2021, 4:00pm

By Jessica Skarzynski

Video

In an interview, Dr. Matthew Davids of the Dana-Farber Cancer Institute discusses the future of CAR T-Cell therapy in the treatment of younger patients with chronic lymphocytic leukemia.

In Cancer Caregiving, a Passion for Learning is Vital

January 18th 2021, 2:00pm

By Jessica Skarzynski

Article

Caregiving for a patient with cancer is an ongoing journey that also requires the caregiver to learn along the way. One couple discusses that process and more.

Count Me Among The Breast Cancer Recurrence Project

January 17th 2021, 7:00pm

By Martha Carlson

Article

The Breast Cancer Recurrence Project aims to revolutionize and bring accuracy to what we know about who’s living with metastatic breast cancer.

Counseling, Targeted Interventions Needed to Improve Health-Related Quality of Life in Young Colon Cancer Survivors

January 17th 2021, 3:00pm

By Conor Killmurray

Article

The researchers concluded that the overall low health-related quality of life scores for young CRC survivors in the categories of social and functional well-being should be targeted by appropriate methods, which could include counseling and quality of life interventions.

Celebrating A ‘Cancerversary’ In A COVID-19 World

January 16th 2021, 8:00pm

By Kelly Irvin

Article

It’s okay for me to not feel like celebrating my 5-year cancerversary in a world that is upside down and backward because of COVID-19. Yes, I’m grateful and blessed, but I’m not bullet-proof. I’m human. I don’t have to feel guilty. None of us do.